SELLAS Life Sciences SLS
NASDAQ SLS
$11.80 +0.47 (+4.15%)
As of: Oct 2, 2026 · 11:18 AM EDT

SELLAS Life Sciences (SLS) Depreciation & Amortization (CF) (2010 - 2017)

Updated

SELLAS Life Sciences (SLS) recorded Depreciation & Amortization (CF) of $25,000 in Q3 2017, down 16.7% from $30,000 a year earlier and unchanged from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Depreciation & Amortization (CF) (2010 - 2017) Analysis & Trends

On a TTM basis, SELLAS Life Sciences' Depreciation & Amortization (CF) came in at -$16,000 as of Sep 30, 2017; for FY2016, it was $3,000, down 97.2% from FY2015.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of -55.0% (FY2011 to FY2016).
  • Across earlier years, Depreciation & Amortization (CF) came in at $107,000 in FY2015 (+24.4%), $86,000 in FY2014 (-69.9%), $286,000 in FY2013 (+483.7%) and $49,000 in FY2012 (-69.9%).
  • Quarterly Depreciation & Amortization (CF) has ranged from -$254,000 in Q4 2014 to $232,000 in Q1 2014 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in 1 of the last six quarters, with growth averaging 10.1%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 487.2% in Q2 2014, against a decline of 95.2% in Q1 2013 at the low end.
  • Per Business Quant, the preceding three quarters came in at $25,000 (Q2 2017), $26,000 (Q1 2017) and -$92,000 (Q4 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 SELLAS Life Sciences 2.49 Bn 2.49 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 25,000.00
Jun 30, 2017 25,000.00
Mar 31, 2017 26,000.00
Dec 31, 2016 -92,000.00
Sep 30, 2016 30,000.00
Jun 30, 2016 59,000.00
Mar 31, 2016 6,000.00
Dec 31, 2015 -197,000.00
Sep 30, 2015 123,000.00
Jun 30, 2015 83,000.00
Mar 31, 2015 98,000.00
Dec 31, 2014 -254,000.00
Sep 30, 2014 -121,000.00
Jun 30, 2014 229,000.00
Mar 31, 2014 232,000.00
Dec 31, 2013 118,000.00
Sep 30, 2013 127,000.00
Jun 30, 2013 39,000.00
Mar 31, 2013 2,000.00
Dec 31, 2012 2,000.00
API Access

SELLAS Life Sciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SLS&period=max&api_key=YOUR_API_KEY